September 2026

Microplastics and Sleep: What’s Real vs. What’s Marketing

Concern about microplastics is legitimate at a general health level: these particles have been genuinely detected in human blood, lungs, placenta, and, in a notable 2024 study, brain tissue. What’s much less established, despite a wave of social media and mattress-marketing content connecting the dots for you, is any direct research linking microplastics specifically to

Microplastics and Sleep: What’s Real vs. What’s Marketing Read More »

Peptides and Sleep: What the FDA Panel Actually Voted On

In July 2026, the FDA’s Pharmacy Compounding Advisory Committee narrowly recommended six experimental peptides, including Epitalon, which is promoted for sleep and longevity, for the 503A Bulks List, a decision that has already generated significant scrutiny. Three things are worth understanding clearly. First, this vote is not FDA approval: it’s a recommendation about whether compounding

Peptides and Sleep: What the FDA Panel Actually Voted On Read More »

CGM and Sleep: What the New Research Actually Shows

Continuous glucose monitors (CGMs) have moved from a diabetes management tool into a mainstream biohacking product, now available over the counter without a prescription (Dexcom’s Stelo, Abbott’s Lingo), often marketed with promises about optimizing sleep through glucose insights. The underlying bidirectional relationship between sleep and blood glucose is real and reasonably well-established, but mostly in

CGM and Sleep: What the New Research Actually Shows Read More »